https://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-studyContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-studyhttps://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-study#u24535Sat, 04 Jul 2026 14:30:44 +0000Recent research indicates that adults using GLP-1 receptor agonists experience a significant drop in physical activity. This trend contributes to the loss of lean muscle mass during weight reduction. Experts recommend combining resistance training and protein intake to mitigate these effects.What's confirmed:GLP-1 weight loss drugs trigger a significant drop in muscle-preserving physical activity.Fitbit data from 750 adults showed daily movement and exercise levels declined after starting GLP-1 drugs.Ozempic and Wegovy cause 25-45% of weight lost to come from lean mass.Resistance training and https://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-studyhttps://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-study#u11922Wed, 24 Jun 2026 23:01:43 +0000A study presented at ENDO 2026 found that adults with obesity using GLP-1 receptor agonist medications decreased their physical activity. This trend raises concerns about muscle loss during rapid weight loss. Experts suggest protein and resistance training to maintain strength.What's confirmed:Adults with obesity using GLP-1 receptor agonist medications significantly decreased their physical activity.Physical activity is essential to protect muscle during weight loss.GLP-1 medications include drugs such as Ozempic, Wegovy, semaglutide, and tirzepatide.Still unconfirmed:GLP-1 users walk 560 few https://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-studyhttps://www.live-feeds.com/feed/people-on-glp-1-drugs-appear-to-do-less-physical-activity-study#u8257Mon, 22 Jun 2026 10:36:20 +0000A study of 753 users indicates that people taking GLP-1 drugs like Ozempic and Wegovy move less after starting treatment. This decline in activity raises concerns regarding muscle loss and long-term health. Researchers emphasize that exercise remains essential for those using these therapies.What's confirmed:Users of GLP-1 weight loss drugs such as Ozempic and Wegovy showed a decrease in physical activity.An ENDO 2026 study of 753 users found daily steps dropped by 560.Daily moderate-to-vigorous physical activity decreased from 28 minutes to 22 minutes.Daily steps for participants fell from ap